Boston Scientific Corp (BSX.N)
28.84USD
20 Apr 2018
$-0.05 (-0.17%)
$28.89
$28.93
$29.14
$28.83
2,118,566
1,990,455
$29.92
$24.54
Latest Key Developments (Source: Significant Developments)
Boston Scientific Prevails In European Patent Dispute With Edwards Lifesciences
April 16 (Reuters) - Boston Scientific Corp
Boston Scientific Announces Acquisition Of NVision Medical Corp
April 16 (Reuters) - Boston Scientific Corp
Boston Scientific Receives U.S. FDA Approval For Spectra Wavewriter Spinal Cord Stimulator System
Jan 11 (Reuters) - Boston Scientific Corp
Boston Scientific Announces Preliminary Unaudited Sales For Q4 and FY17
Jan 9 (Reuters) - Boston Scientific Corp
Boston Scientific Receives FDA Approval For Vercise Deep Brain Stimulation System
Dec 11 (Reuters) - Boston Scientific Corp
Appaloosa LP cuts share stake in BofA, dissolves share stake in Wells Fargo and Activision Blizzard
Nov 14 (Reuters) - APPALOOSA LP:Appaloosa LP dissolves share stake in Activision Blizzard Inc - SEC filing.Appaloosa LP cuts share stake in Bank Of America Corp by about 28 percent to 6.3 million shares.Appaloosa LP raises share stake in Boston Scientific Corp by about 66 percent to 3.8 million shares.Appaloosa LP dissolves share stake in L Brands Inc.Appaloosa LP dissolves share stake in Wells Fargo.Appaloosa LP cuts share stake in Dollar General Corp by 36 percent to 599,264 shares.Appaloosa LP raises share stake in NRG Energy Inc to 8.4 million shares from 1.3 million shares.Appaloosa LP - Change in holdings are as of Sept 30, 2017 and compared with the previous quarter ended as of June 30, 2017.Source text for quarter ended Sept 30, 2017 (http://bit.ly/2zJRjl2).Source text for quarter ended June 30, 2017: (http://bit.ly/2uWm5mq). Full Article
Boston Scientific announces results for third quarter 2017
Oct 26 (Reuters) - Boston Scientific Corp
Neovasc and Boston Scientific closes $75 million agreement
Neovasc Inc
Boston Scientific's unit Falcon Merger extends offer for all shares of EndoChoice Holdings
Boston Scientific Corp
EndoChoice holdings agreement with Boston Scientific provides termination fee of $7.95 million under certain circumstances
Endochoice Holdings Inc
BRIEF-Boston Scientific Prevails In European Patent Dispute With Edwards Lifesciences
* BOSTON SCIENTIFIC PREVAILS IN EUROPEAN PATENT DISPUTE WITH EDWARDS LIFESCIENCES